Ocrevus (ocrelizumab) and Ocrevus Zunovo (ocrelizumab/hyaluronidase-ocsq) are prescription medicines for multiple sclerosis (MS). Both contain the medicine ...
Multiple sclerosis (MS) is a chronic, often disabling condition that affects the central nervous system, disrupting communication between the brain and body. It’s largely thought to occur when the ...
More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, ...
Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for ...